Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Rtw Biotech (RTW) Share Price

Price $1.845 on 14-11-2025 at 19:30:07
Change $0.00 0%
Buy $1.855
Sell $1.845
Last Trade: Sell 973.00 at $1.845
Day's Volume: 547,171
Last Close: $1.845
Open: $1.82
ISIN: GG00BKTRRM22
Day's Range $1.82 - $1.855
52wk Range: $1.08 - $1.855
Market Capitalisation: $603.73m
VWAP: $1.84121
Shares in Issue: 327.22m

Rtw Biotech (RTW) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 973 $1.845 SI Trade
16:35:21 - 14-Nov-25
Sell* 302 $1.845 SI Trade
16:35:21 - 14-Nov-25
Sell* 107 $1.845 SI Trade
16:35:21 - 14-Nov-25
Sell* 234 $1.845 SI Trade
16:35:21 - 14-Nov-25
Sell* 3 $1.845 SI Trade
16:35:21 - 14-Nov-25
Sell* 294 $1.845 SI Trade
16:35:21 - 14-Nov-25
Sell* 50 $1.845 SI Trade
16:35:21 - 14-Nov-25
Sell* 5 $1.845 SI Trade
16:35:21 - 14-Nov-25
Buy* 26,872 $1.845 Suspected BUY Trade
16:35:21 - 14-Nov-25
Buy* 67,385 $1.8525 Suspected BUY Trade
16:29:34 - 14-Nov-25
See more Rtw Biotech trades

Rtw Biotech (RTW) Share Price History

Time period:
to
Date Open High Low Close Volume
14th Nov 2025 (Fri) 1.82 1.855 1.82 1.845 547,171
13th Nov 2025 (Thu) 1.82 1.85 1.82 1.845 73,505
12th Nov 2025 (Wed) 1.79 1.84 1.79 1.82 137,019
11th Nov 2025 (Tue) 1.80 1.82 1.77 1.815 609,417
10th Nov 2025 (Mon) 1.80 1.82 1.785 1.80 461,409
7th Nov 2025 (Fri) 1.81 1.825 1.79 1.79 544,594
6th Nov 2025 (Thu) 1.81 1.82 1.80 1.80 127,777
5th Nov 2025 (Wed) 1.775 1.815 1.775 1.81 349,300
4th Nov 2025 (Tue) 1.74 1.805 1.74 1.795 788,242
3rd Nov 2025 (Mon) 1.75 1.795 1.75 1.76 754,920
31st Oct 2025 (Fri) 1.79 1.79 1.765 1.765 166,307
30th Oct 2025 (Thu) 1.79 1.79 1.76 1.775 310,843
29th Oct 2025 (Wed) 1.75 1.79 1.75 1.78 400,243
28th Oct 2025 (Tue) 1.79 1.79 1.76 1.76 609,463
27th Oct 2025 (Mon) 1.725 1.785 1.725 1.765 1,249,262
24th Oct 2025 (Fri) 1.70 1.715 1.695 1.70 1,560,638
23rd Oct 2025 (Thu) 1.65 1.69 1.65 1.69 291,222
22nd Oct 2025 (Wed) 1.65 1.655 1.645 1.65 2,685,494
21st Oct 2025 (Tue) 1.64 1.645 1.63 1.63 2,080,736
20th Oct 2025 (Mon) 1.62 1.64 1.61 1.635 1,445,215
17th Oct 2025 (Fri) 1.62 1.63 1.585 1.63 367,160
16th Oct 2025 (Thu) 1.62 1.63 1.605 1.63 205,549
15th Oct 2025 (Wed) 1.605 1.62 1.585 1.62 245,193
See more Rtw Biotech price history

Rtw Biotech (RTW) Regulatory News

Date Source Headline
14th Nov 2025 7:00 am RNS Monthly Valuation Update and Factsheet
7th Nov 2025 7:00 am RNS Evommune announces $150 million IPO
5th Nov 2025 10:00 am RNS Holding(s) in Company
3rd Nov 2025 9:33 am RNS Total Voting Rights
31st Oct 2025 7:00 am RNS Royalty Funding Agreement with Savara Inc.
29th Oct 2025 7:00 am RNS Transaction in Own Shares
27th Oct 2025 7:00 am RNS Novartis to acquire Avidity Biosciences
20th Oct 2025 7:00 am RNS Capital Allocation Plan based on M&A successes
15th Oct 2025 7:00 am RNS Kailera Therapeutics announces Series B financing
14th Oct 2025 7:00 am RNS Monthly Valuation Update and Factsheet
See more Rtw Biotech regulatory news

Rtw Biotech (RTW) Share News

RTW Biotech notes investee Evommune's USD150 million IPO raise

7th Nov 2025 12:46

(Alliance News) - RTW Biotech Opportunities Ltd on Friday noted one of its private portfolio companies Evommune Inc raised USD150 million in its initial public offering. Read More

RTW Biotech announces royalty funding agreement with Savara

31st Oct 2025 11:37

(Alliance News) - RTW Biotech Opportunities Ltd on Friday confirmed it has entered into a royalty funding agreement with clinical stage biopharmaceutical company Savara Inc for a rare lung disease treatment. Read More

RTW Biotech hails Novartis acquisition of investee Avidity

27th Oct 2025 11:41

(Alliance News) - RTW Biotech Opportunities Ltd on Monday noted that Swiss pharmaceutical major Novartis AG has definitively agreed to buy portfolio company Avidity Biosciences Inc. Read More

IN BRIEF: RTW Biotech Opportunities extends buyback by USD15 million

20th Oct 2025 10:34

RTW Biotech Opportunities Ltd - Guernsey-based investor in life sciences sector - Adds USD15 million to share buyback programme, aiming to close the discount of its share price to net asset value. RTW Biotech has USD5.8 million to complete from its current USD30 million buyback and will top that up by USD15 million, which is equivalent to about 9.2 million shares. Funds for the buyback come from several recent realisations of portfolio holdings. The company's most recently report net asset value, as of June 30, was USD1.70. Read More

RTW Biotech invests USD7.4 million in financing round for Kailera

15th Oct 2025 13:17

(Alliance News) - RTW Biotech Opportunities Ltd said on Wednesday that it invested USD7.4 million in Kailera Therapeutics Inc for the company's USD600 million Series B financing round. Read More

See more Rtw Biotech news
FTSE 100 Latest
Value9,698.37
Change-109.31

Login to your account

Forgot Password?

Not Registered